Merit Medical Systems Insiders Sold US$556k Of Shares Suggesting Hesitancy
CCORF Maintains Merit Medical Systems(MMSI.US) With Buy Rating, Maintains Target Price $127
Needham Maintains Merit Medical Systems(MMSI.US) With Buy Rating, Maintains Target Price $109
Analysts Offer Insights on Healthcare Companies: Boston Scientific (BSX), Vivani Medical (VANI) and Merit Medical Systems (MMSI)
Merit Medical Systems Says Wrapsody Endoprosthesis Receives FDA Premarket Approval
Express News | Merit Medical Systems Inc - to Begin Commercialization of Wrapsody in USA in 2025
Merit Medical Announces FDA Approval of the WRAPSODY Cell-Impermeable Endoprosthesis
Express News | Merit Medical Announces FDA Approval of the Wrapsody Cell-Impermeable Endoprosthesis
Merit Medical Systems Announces Leadership Change Amid Investigation
Express News | Merit Medical Systems- in Connection With . Wright's Resignation, Entered Separation Agreement Dated Dec 16
Price Over Earnings Overview: Merit Medical Systems
Merit Financial Advisors Partners With Roth Asset Management and Expands Presence in Pacific Northwest
Wells Fargo Maintains Merit Medical Systems(MMSI.US) With Buy Rating, Maintains Target Price $120
BofA Securities Maintains Merit Medical Systems(MMSI.US) With Hold Rating, Maintains Target Price $103
Positive Outlook for Merit Medical Systems Amid Leadership Transition and Imminent Wrapsody Approval
Merit Medical Announces Resignation Of President, Joseph Wright, Effective January 3, 2025; Board Of Directors Has Re-Appointed Fred P. Lampropoulos As Merit's President
Merit Medical Has Re-Appointed Fred P. Lampropoulos as Merit's President >MMSI
Merit Medical Independent Directors Investigated Allegations With the Assistance of Independent Counsel >MMSI
Merit Medical: Allegations Were Unrelated to Merit's Ops or Fincl Performance >MMSI
Merit Medical Had Received Prior Notice of Allegations Regarding Wright's Conduct >MMSI